ID: ALA5268605
Chembl Id: CHEMBL5268605
Max Phase: Preclinical
Molecular Formula: C17H26N2O3
Molecular Weight: 306.41
Associated Items:
Canonical SMILES: CCCCCCCC(=O)OCCc1ccc(N/C=N/O)cc1
Standard InChI: InChI=1S/C17H26N2O3/c1-2-3-4-5-6-7-17(20)22-13-12-15-8-10-16(11-9-15)18-14-19-21/h8-11,14,21H,2-7,12-13H2,1H3,(H,18,19)
Standard InChI Key: KPQVTFAUFGPCHU-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 306.41 | Molecular Weight (Monoisotopic): 306.1943 | AlogP: 3.96 | #Rotatable Bonds: 11 |
| Polar Surface Area: 70.92 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
| #RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 11.51 | CX Basic pKa: 2.22 | CX LogP: 4.06 | CX LogD: 4.06 |
| Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.16 | Np Likeness Score: -0.15 |
| 1. Yuan Y, Yao H, Zhou M, Ma X, Zhou Y, Xu J, Niu M, Yin J, Zheng L, Xu S.. (2022) Identification of a Novel Potent CYP4Z1 Inhibitor Attenuating the Stemness of Breast Cancer Cells through Lead Optimization., 65 (23.0): [PMID:36414390] [10.1021/acs.jmedchem.2c01320] |
Source(1):
